Fast growth for recently label-expanded drugs fuelled Novartis’ Q3 performance, despite headwinds from generic competition.

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Clarity Pharmaceuticals Ltd. (($AU:CU6)) announced an update on their ongoing clinical study. Clarity Pharmaceuticals Ltd. is conducting a Phase 3 ...

Struggling with frequent bathroom trips or a weak urine stream? Learn how to manage BPH with personalized care, from ...

Microsoft Edge has morphed into a full-fledged AI browser that can even shop for you. So, I put it to the test.

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions ...

The center will be located on the Penn Med Princeton Medical Center campus, marking the largest expansion of Princeton Health ...

Expedition Medicines has emerged from stealth with $50 million in funding from Flagship Pioneering. The start-up uses ...

FOR countless people across Ireland, the simple act of laughing, coughing, or rushing for the bus comes with a hidden worry.

Taking a club from a village of 1,485 next to the Baltic Sea to an unprecedented league title and Champions League qualifying ...